Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Blood Research|April 2, 2021
An updated account on molecular heterogeneity of acute leukemiaEkta Rahul, Harsh Goel, Anita Chopra, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 31, 2025
Integrative Genetic and Transcriptomic Subtyping Improves Prognosis Prediction in B-Lineage Acute Lymphoblastic LeukemiaMercilena Benjamin, Jay Singh, Avanish Kumar Pandey, et al.
American Journal of Blood Research|November 26, 2021
Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemiaHarsh Goel, Ekta Rahul, Ishan Gupta, et al.
Journal of Immunology Research|March 11, 2026
Cytokine Signatures Outperform Immune Subsets in Machine Learning Models for Predicting Acute Graft-Versus-Host Disease at Neutrophil EngraftmentMohini Mendiratta, Praful Pandey, Shobhit Pandey, et al.
Cancers|June 13, 2025
RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid LeukemiaHarsh Goel, Avanish Kumar Pandey, Rahul Kumar, et al.
Iscience|April 20, 2026
Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton's jelly mesenchymal stem cellsMohini Mendiratta, Meenakshi Mendiratta, Sujata Mohanty, et al.
Cancers|May 27, 2026
Integrated Genomic Profiling of Newly Diagnosed and Relapsed Acute Myeloid Leukemia Identifies Driver Genes, Mutational Signatures, and Therapeutic TargetsHarsh Goel, Avanish Kumar Pandey, Anshul Arya, et al.
Discover Oncology|June 21, 2026
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)Jagdish Prasad Meena, Debasish Sahoo, Harshita Makkar, et al.
Stem Cell Research & Therapy|October 29, 2024
Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease modelMohini Mendiratta, Meenakshi Mendiratta, Shuvadeep Ganguly, et al.
Journal of Tropical Pediatrics|June 21, 2021
Clinical Profile and Risk Factors for Severe Disease in 402 Children Hospitalized with SARS-CoV-2 from India: Collaborative Indian Pediatric COVID Study GroupKana Ram Jat, Jhuma Sankar, Rashmi Ranjan Das, et al.
Pageof 9